| 1 |
30428496 | Hypoglycemia and Glucagon Utilization in Insulin-Treated Diabetic Patients. | 2020 Aug |
1 |
| 2 |
31179612 | Impaired early-phase suppression of glucagon secretion after glucose load is associated with insulin requirement during pregnancy in gestational diabetes. | 2020 Jan |
1 |
| 3 |
31240874 | Pancreatic fat is related to the longitudinal decrease in the increment of C-peptide in glucagon stimulation test in type 2 diabetes patients. | 2020 Jan |
2 |
| 4 |
30619718 | Metabolic effects of glucagon in humans. | 2019 Mar |
3 |
| 5 |
30623165 | Relationship Between Fasting Plasma Glucagon Level and Renal Function-A Cross-Sectional Study in Individuals With Type 2 Diabetes. | 2019 Jan 1 |
1 |
| 6 |
30635569 | Insulin inhibits glucagon release by SGLT2-induced stimulation of somatostatin secretion. | 2019 Jan 11 |
1 |
| 7 |
30644734 | Electrochemical Aptamer-Based Sensor for Real-Time Monitoring of Insulin. | 2019 Feb 22 |
1 |
| 8 |
30713129 | Short Chain Fatty Acids, pancreatic dysfunction and type 2 diabetes. | 2019 Mar |
1 |
| 9 |
30893335 | Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon. | 2019 |
2 |
| 10 |
31019402 | Technology for Augmenting Type 1 Diabetes Mellitus Management. | 2019 Mar-Apr |
1 |
| 11 |
31086331 | Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme. | 2019 Jun |
1 |
| 12 |
31193194 | Positive correlation between fasting plasma glucagon and serum C-peptide in Japanese patients with diabetes. | 2019 May |
1 |
| 13 |
31349701 | Therapeutic Use of Intranasal Glucagon: Resolution of Hypoglycemia. | 2019 Jul 25 |
1 |
| 14 |
28494143 | Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity. | 2018 Mar |
1 |
| 15 |
28922582 | Relationship between Optimum Mini-doses of Glucagon and Insulin Levels when Treating Mild Hypoglycaemia in Patients with Type 1 Diabetes - A Simulation Study. | 2018 Mar |
9 |
| 16 |
29034607 | Complete loss of insulin secretion capacity in type 1A diabetes patients during long-term follow up. | 2018 Jul |
1 |
| 17 |
29126197 | Impaired Insulin Action Is Associated With Increased Glucagon Concentrations in Nondiabetic Humans. | 2018 Jan 1 |
3 |
| 18 |
29288524 | Insulin deficiency with and without glucagon: A comparative study between total pancreatectomy and type 1 diabetes. | 2018 Sep |
2 |
| 19 |
29305624 | Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids. | 2018 Mar |
1 |
| 20 |
29314731 | Regulation of amino acid metabolism and α-cell proliferation by glucagon. | 2018 Jan 3 |
1 |
| 21 |
29358493 | Effects of Preceding Ethanol Intake on Glucose Response to Low-Dose Glucagon in Individuals With Type 1 Diabetes: A Randomized, Placebo-Controlled, Crossover Study. | 2018 Apr |
1 |
| 22 |
29374382 | Zinc Supplementation Does Not Affect Glucagon Response to Intravenous Glucose and Insulin Infusion in Patients with Well-Controlled Type 2 Diabetes. | 2018 Oct |
1 |
| 23 |
29393039 | Glucagon treatment in type 1 diabetes -with focus on restoring plasma glucose during mild hypoglycemia
. | 2018 Feb |
3 |
| 24 |
29408994 | Impact of C-Peptide Status on the Response of Glucagon and Endogenous Glucose Production to Induced Hypoglycemia in T1DM. | 2018 Apr 1 |
2 |
| 25 |
29427469 | Analysis of pancreatic volume in acute-onset, slowly-progressive and fulminant type 1 diabetes in a Japanese population. | 2018 Sep |
1 |
| 26 |
29466430 | Cholinergic signaling mediates the effects of xenin-25 on secretion of pancreatic polypeptide but not insulin or glucagon in humans with impaired glucose tolerance. | 2018 |
1 |
| 27 |
29669745 | GPR119 Agonism Increases Glucagon Secretion During Insulin-Induced Hypoglycemia. | 2018 Jul |
1 |
| 28 |
29910091 | Meal-derived glucagon responses are related to lower hepatic phosphate concentrations in obesity and type 2 diabetes. | 2018 Nov |
1 |
| 29 |
30035620 | GLUCAGON PRESCRIPTIONS FOR DIABETES PATIENTS AFTER EMERGENCY DEPARTMENT VISITS FOR HYPOGLYCEMIA. | 2018 Oct 2 |
1 |
| 30 |
30070610 | Insulin inhibits autophagy signaling independent of counter-regulatory hormone levels, but does not affect the effects of exercise. | 2018 Aug 2 |
1 |
| 31 |
30257978 | Distinct Neuronal Projections From the Hypothalamic Ventromedial Nucleus Mediate Glycemic and Behavioral Effects. | 2018 Dec |
1 |
| 32 |
30325692 | Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects. | 2018 Dec |
1 |
| 33 |
27448377 | Modeling Glucagon Action in Patients With Type 1 Diabetes. | 2017 Jul |
4 |
| 34 |
27629286 | Glucagon in artificial pancreas systems: Potential benefits and safety profile of future chronic use. | 2017 Jan |
1 |
| 35 |
27797928 | Low-Carbohydrate Diet Impairs the Effect of Glucagon in the Treatment of Insulin-Induced Mild Hypoglycemia: A Randomized Crossover Study. | 2017 Jan |
1 |
| 36 |
27889949 | Undercarboxylated osteocalcin can predict insulin secretion ability in type 2 diabetes. | 2017 Jul |
1 |
| 37 |
28007055 | Physiological and pathophysiological aspects of incretin hormones and glucagon. | 2017 Jan |
1 |
| 38 |
28188284 | Glucagon and Insulin Cooperatively Stimulate Fibroblast Growth Factor 21 Gene Transcription by Increasing the Expression of Activating Transcription Factor 4. | 2017 Mar 31 |
1 |
| 39 |
28371189 | Effect of GLP-1 and GIP on C-peptide secretion after glucagon or mixed meal tests: Significance in assessing B-cell function in diabetes. | 2017 Sep |
1 |
| 40 |
28391069 | Insulin and glucagon in plasma and cerebrospinal fluid in suicide attempters and healthy controls. | 2017 Jul |
2 |
| 41 |
28521865 | Exaggerated glucagon responses to hypoglycemia in women with polycystic ovary syndrome. | 2017 Jun |
1 |
| 42 |
28556672 | Faster Use and Fewer Failures with Needle-Free Nasal Glucagon Versus Injectable Glucagon in Severe Hypoglycemia Rescue: A Simulation Study. | 2017 Jul |
2 |
| 43 |
28654314 | Cross-Validation of a Glucose-Insulin-Glucagon Pharmacodynamics Model for Simulation Using Data From Patients With Type 1 Diabetes. | 2017 Nov |
1 |
| 44 |
28881681 | Insulin-like growth factor-1 is a negative modulator of glucagon secretion. | 2017 Aug 1 |
2 |
| 45 |
28887444 | Insulin, glucagon and somatostatin stores in the pancreas of subjects with type-2 diabetes and their lean and obese non-diabetic controls. | 2017 Sep 8 |
3 |
| 46 |
28911141 | Glucagon Decreases IGF-1 Bioactivity in Humans, Independently of Insulin, by Modulating Its Binding Proteins. | 2017 Sep 1 |
1 |
| 47 |
28929796 | A coordinated control strategy for insulin and glucagon delivery in type 1 diabetes. | 2017 Oct |
1 |
| 48 |
29031727 | Angiopoietin-like protein 4 is an exercise-induced hepatokine in humans, regulated by glucagon and cAMP. | 2017 Oct |
2 |
| 49 |
26426957 | Needle-free nasal delivery of glucagon for treatment of diabetes-related severe hypoglycemia: toxicology of polypropylene resin used in delivery device. | 2016 Sep |
2 |
| 50 |
26484405 | GLUCAGON PRESCRIPTION PATTERNS IN PATIENTS WITH EITHER TYPE 1 OR 2 DIABETES WITH NEWLY PRESCRIBED INSULIN. | 2016 Feb |
2 |